{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/agilent-technologies-a/",
 "dataUrl": "https://clearank.com/stock/agilent-technologies-a/data.json",
 "title": "Agilent (A) Stock Forecast & Price Target (2026)",
 "description": "Is Agilent Technologies (A) a Buy or Sell today? AI price target, moving average signals and valuation risk in one view. Updated daily.",
 "headline": "Agilent Technologies, Inc. (A)",
 "published": "2026-08-26T09:27:16+00:00",
 "modified": "2026-09-09T23:33:15.57+00:00",
 "generated": "2026-09-11T20:41:54.619Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "A",
  "name": "Agilent Technologies Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Diagnostics & Research",
  "country": "United States",
  "website": "https://www.agilent.com"
 },
 "quote": {
  "price": 143.12,
  "previousClose": 144.75,
  "change": -1.63,
  "changePercent": -1.13,
  "open": 142.58,
  "high": 144.145,
  "low": 141.25,
  "volume": 1520258,
  "averageVolume": 2383906,
  "marketCap": 40809201616,
  "fiftyTwoWeekHigh": 163.75,
  "fiftyTwoWeekLow": 108.35,
  "marketOpen": false,
  "asOf": "2026-09-09T23:33:14.000Z"
 },
 "statistics": {
  "pe": 28.964497,
  "eps": 5.07,
  "dividendYield": 0.007045172044481721,
  "beta": 1.241,
  "priceToSales": 5.6160135,
  "priceToBook": 5.623636,
  "revenueTtm": 7372000256,
  "grossMargin": 0.5548455804046858,
  "returnOnEquity": 0.20971
 },
 "technicals": {
  "rsi": 32.83,
  "macd": 1.49,
  "sma50": 142.78,
  "sma200": 131.61,
  "rsiSignal": "Bearish",
  "trend": "Bullish",
  "pricePosition": "Bullish",
  "macdSignal": "Bullish",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 73,
  "consensus": "Buy",
  "fairValue": 177.5,
  "analystTarget": 177.5,
  "analystCount": 22,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-09T23:33:14.000Z",
  "priceAtAnalysis": 143.12,
  "volatility": {
   "daily": 1.7,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 140.26,
  "aggressiveEntry": 143.12,
  "stopLoss": 135.95,
  "stopLossPercent": 3.07,
  "targets": [
   147.27,
   154.28,
   161.3
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 109.49,
    "base": 157.21,
    "upside90th": 225.71
   },
   {
    "year": 2028,
    "downside10th": 103.53,
    "base": 172.68,
    "upside90th": 288
   },
   {
    "year": 2029,
    "downside10th": 101.37,
    "base": 189.67,
    "upside90th": 354.89
   },
   {
    "year": 2030,
    "downside10th": 101.07,
    "base": 208.34,
    "upside90th": 429.49
   },
   {
    "year": 2031,
    "downside10th": 101.93,
    "base": 228.85,
    "upside90th": 513.81
   },
   {
    "year": 2032,
    "downside10th": 103.64,
    "base": 251.37,
    "upside90th": 609.67
   },
   {
    "year": 2033,
    "downside10th": 106.04,
    "base": 276.11,
    "upside90th": 718.94
   },
   {
    "year": 2034,
    "downside10th": 109.03,
    "base": 303.29,
    "upside90th": 843.64
   },
   {
    "year": 2035,
    "downside10th": 112.55,
    "base": 333.14,
    "upside90th": 986.01
   },
   {
    "year": 2036,
    "downside10th": 116.58,
    "base": 365.92,
    "upside90th": 1148.53
   }
  ]
 },
 "faqCount": 8,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "A Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$142.58",
    "Day Range": "$141.25 to $144.15",
    "Prev Close": "$144.75",
    "Volume": "1.52M",
    "52-Week Range": "$108.35 to $163.75",
    "Market Cap": "$40.81B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Valuation is broadly in line with sector peers (0.0155% difference), suggesting fair market pricing relative to industry standards."
   ]
  },
  {
   "id": "analysis",
   "title": "A Analysis",
   "text": [
    "Agilent Technologies (A) is currently trading below its 20-day EMA at $149.63, indicating short-term weakness, and its RSI is in bearish territory at 32.83. The stock is trading above its 50-day SMA of $142.78 and its 200-day SMA of $131.61, suggesting that longer-term support levels remain intact. Volume has been below average recently, with the latest volume at 1.84 million compared to a 2.55 million average. Key support is seen around the 50-day SMA, while resistance may form near the 20-day EMA. The current technical setup suggests a potential for a near-term pullback before a possible recovery, contingent on broader market sentiment and company-specific news.",
    "Agilent Technologies (A) has a strong history of exceeding analyst EPS estimates, with the latest quarter showing an 8.72% surprise. This trend supports a positive outlook and potential for stock price appreciation.",
    "With 22 analysts covering the stock, the consensus is predominantly 'Buy', and the median price target of $177.50 suggests a 22.6% upside from current levels.",
    "Insiders have sold $4.2 million worth of stock with no reported purchases, indicating a net selling trend. This 'Moderate Sell Signal' warrants monitoring for any acceleration.",
    "Projected revenue growth of 8.1% for the current year and 6.0% for the next provides a stable foundation, though not explosive growth, for the company's valuation.",
    "Agilent Technologies (A) is expected to maintain its positive trajectory over the next 6-12 months, driven by continued revenue growth and strong analyst support. The median price target of $177.50 suggests a base case scenario where the stock could appreciate by over 22% from its current price. Potential catalysts include further innovation in its diagnostic and research segments, successful integration of any new product launches, and continued positive earnings surprises. Downside risks could emerge from increased competition, unexpected regulatory changes in the healthcare sector, or a broader market downturn that impacts growth stocks."
   ],
   "lists": {
    "ProTips": [
     "Consider the current bearish technical momentum (RSI 32.83) as a potential entry point for long-term investors, given the strong analyst 'Buy' consensus and positive earnings trend.",
     "Monitor upcoming earnings reports closely; consistent beats have historically driven positive price action for Agilent Technologies (A).",
     "Given the moderate insider selling, it is prudent to focus on fundamental strength and analyst targets rather than insider activity as the primary investment driver."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Consistent EPS Beats Drive Positive Sentiment",
     "text": "Agilent Technologies (A) has a strong history of exceeding analyst EPS estimates, with the latest quarter showing an 8.72% surprise. This trend supports a positive outlook and potential for stock price appreciation.",
     "source": "Earnings Reports"
    },
    {
     "type": "Bullish",
     "title": "Strong Analyst Conviction and Price Targets",
     "text": "With 22 analysts covering the stock, the consensus is predominantly 'Buy', and the median price target of $177.50 suggests a 22.6% upside from current levels.",
     "source": "Wall Street Analysts"
    },
    {
     "type": "Bearish",
     "title": "Moderate Insider Selling Activity",
     "text": "Insiders have sold $4.2 million worth of stock with no reported purchases, indicating a net selling trend. This 'Moderate Sell Signal' warrants monitoring for any acceleration.",
     "source": "Insider Transactions"
    },
    {
     "type": "Neutral",
     "title": "Steady Revenue Growth Projections",
     "text": "Projected revenue growth of 8.1% for the current year and 6.0% for the next provides a stable foundation, though not explosive growth, for the company's valuation.",
     "source": "Revenue Estimates"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Agilent Technologies (A) trades at a P/E ratio of 28.96, which aligns with its sector average for Healthcare Diagnostics & Research. The company has demonstrated consistent revenue growth, with an 8.1% increase reported for the current year and an estimated 6.0% for the next. Profitability is solid, as indicated by a positive EPS of $5.07. The balance sheet appears healthy. The company's ability to consistently beat earnings estimates suggests strong operational execution and a strong business model, supporting its current valuation and analyst price targets.",
    "Agilent Technologies (A) has a strong track record of exceeding analyst EPS expectations, with the most recent quarter (August 2026) showing an actual EPS of $1.62 against an estimate of $1.49, a positive surprise of 8.72%. This follows a pattern of positive surprises in prior quarters, with the exception of a minor miss in February 2026. The stock reacted positively to the latest earnings beat, gaining 1.68%. Revenue growth has been consistently positive, reinforcing the company's ability to grow its top line.",
    "A primary risk for Agilent Technologies (A) is the current bearish technical momentum, with the RSI indicating oversold conditions and the stock trading below its 20-day EMA. Moderate insider selling, with $4.2 million in sales versus no purchases, also warrants attention, although the overall verdict is 'Moderate Sell Signal' rather than a strong bearish indicator. Additionally, potential shifts in healthcare spending or increased competition within the diagnostics and research market could impact future growth."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "40.81B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "28.96"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "5.07"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.6997%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "163.75"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "108.35"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Bearish SMA Cross Bullish Price vs SMA Bullish MACD Bullish Golden Cross in effect with the 50-day SMA ($142.78) above the 200-day SMA ($131.61), price action is firmly bullish above key moving averages."
   ],
   "facts": {
    "RSI": "Bearish",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bullish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "32.83"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "1.49"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "142.78"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "131.61"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.51",
    "Correlation with Nasdaq 100 (QQQ)": "+0.42",
    "Correlation with Bitcoin (BTC)": "+0.03",
    "Correlation with Gold (XAU)": "+0.05"
   }
  },
  {
   "id": "trade-plans",
   "title": "A Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (32.8) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$147.27",
    "TARGET 2": "$154.28",
    "TARGET 3": "$161.30",
    "STOP LOSS": "$135.95"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.70%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in A in September 2016 would be worth about $32,721 today, compared with about $35,913 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in A today could grow to about $25,568 by 2036 in the base case, with a bull case near $80,249 and a bear case around $8,146. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "A Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $208 for A by 2030 in the base case, from $143 today (1.5x over 4 years). The downside path ends near $101. These are outcomes of a Monte Carlo simulation run on A's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using A's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "A simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$109",
        "$157",
        "$226"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$104",
        "$173",
        "$288"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$101",
        "$190",
        "$355"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$101",
        "$208",
        "$429"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$102",
        "$229",
        "$514"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$104",
        "$251",
        "$610"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$106",
        "$276",
        "$719"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$109",
        "$303",
        "$844"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$113",
        "$333",
        "$986"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$117",
        "$366",
        "$1,149"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "ELV Elevance Health, Inc. NYSE $416.94 +0.0960%",
     "url": "https://clearank.com/stock/elv-stock-analysis/"
    },
    {
     "text": "ILMN Illumina Inc. NASDAQ $206.28 +2.49%",
     "url": "https://clearank.com/stock/ilmn-stock-analysis/"
    },
    {
     "text": "NVO Novo Nordisk A/S Sponsored NYSE $44.01 -1.23%",
     "url": "https://clearank.com/stock/novo-nordisk-nvo/"
    },
    {
     "text": "QDEL QuidelOrtho Corporation NASDAQ $12.15 -3.88%",
     "url": "https://clearank.com/stock/quidelortho-qdel/"
    },
    {
     "text": "CAPR Capricor Therapeutics, Inc. NASDAQ $8.30 -3.94%",
     "url": "https://clearank.com/stock/capr-stock-analysis/"
    },
    {
     "text": "RXRX Recursion Pharmaceuticals, Inc. NASDAQ $3.20 +1.11%",
     "url": "https://clearank.com/stock/rxrx-stock-analysis/"
    },
    {
     "text": "DHR Danaher Corp. NYSE $200.53 -2.11%",
     "url": "https://clearank.com/stock/dhr-stock-analysis/"
    },
    {
     "text": "ISRG Intuitive Surgical Inc. NASDAQ $358.08 +1.37%",
     "url": "https://clearank.com/stock/intuitive-surgical-isrg/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "VUG vs VGT Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vug-vs-vgt/"
    },
    {
     "text": "NFLX vs DIS Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/nflx-vs-dis/"
    },
    {
     "text": "Workday (WDAY) vs Atlassian (TEAM) Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/workday-vs-atlassian/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "A Insider Trading Analysis",
   "facts": {
    "Bought": "None",
    "Sold": "$4.2M",
    "Insiders": "22",
    "Avg Transaction": "$379.5K"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in A",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Nov 22, 2022",
       "cells": [
        "MCMULLEN MICHAEL R Chief Executive Officer",
        "Sell",
        "128.7K",
        "$20.0M"
       ]
      },
      {
       "label": "Dec 20, 2021",
       "cells": [
        "MCMULLEN MICHAEL R Chief Executive Officer",
        "Sell",
        "123.5K",
        "$18.4M"
       ]
      },
      {
       "label": "Dec 1, 2020",
       "cells": [
        "MCMULLEN MICHAEL R Chief Executive Officer",
        "Sell",
        "85.8K",
        "$9.9M"
       ]
      },
      {
       "label": "Dec 7, 2023",
       "cells": [
        "MCMULLEN MICHAEL R Chief Executive Officer",
        "Sell",
        "62.5K",
        "$8.1M"
       ]
      },
      {
       "label": "Mar 8, 2024",
       "cells": [
        "MCMULLEN MICHAEL R Chief Executive Officer",
        "Sell",
        "52.3K",
        "$7.8M"
       ]
      },
      {
       "label": "Feb 2, 2021",
       "cells": [
        "MCMULLEN MICHAEL R Chief Executive Officer",
        "Sell",
        "63.2K",
        "$7.7M"
       ]
      },
      {
       "label": "Jul 30, 2020",
       "cells": [
        "MCMULLEN MICHAEL R Chief Executive Officer",
        "Sell",
        "72.7K",
        "$7.0M"
       ]
      },
      {
       "label": "Jun 14, 2021",
       "cells": [
        "ANCHER JENSEN HENRIK Officer",
        "Sell",
        "43.7K",
        "$6.3M"
       ]
      },
      {
       "label": "Dec 14, 2022",
       "cells": [
        "ANCHER JENSEN HENRIK Officer",
        "Sell",
        "29.5K",
        "$4.6M"
       ]
      },
      {
       "label": "Dec 10, 2019",
       "cells": [
        "MCMULLEN MICHAEL R Chief Executive Officer",
        "Sell",
        "49.3K",
        "$4.0M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Agilent+Technologies%2C+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is Agilent Technologies (A) stock a buy right now?",
   "answer": "Agilent Technologies (A) is currently rated a 'Buy' by Wall Street analysts, with a median price target of $177.50, suggesting a 22.6% upside from its current price of $144.75. The company has a history of beating earnings estimates and shows consistent revenue growth."
  },
  {
   "question": "What is Agilent Technologies' (A) long-term outlook?",
   "answer": "The long-term outlook for Agilent Technologies (A) appears positive, with a projected 2030 base case price of $210.71 from Monte Carlo simulations. The company is expected to continue its revenue growth trajectory, supported by its strong position in the healthcare diagnostics and research sector."
  },
  {
   "question": "What are the key growth drivers for Agilent Technologies (A)?",
   "answer": "Key growth drivers for Agilent Technologies (A) include its consistent innovation in diagnostics and research, strong execution leading to regular earnings beats, and steady revenue growth projected at 8.1% for the current year. The company's ability to maintain analyst confidence also supports its growth prospects."
  },
  {
   "question": "How has Agilent Technologies (A) performed in recent earnings reports?",
   "answer": "Agilent Technologies (A) has consistently surpassed analyst EPS expectations in recent quarters. The latest report in August 2026 showed an 8.72% positive surprise, and the stock saw a 1.68% increase following the announcement, indicating positive market reception to its earnings performance."
  },
  {
   "question": "What is the consensus rating for Agilent Technologies (A) stock?",
   "answer": "The consensus rating for Agilent Technologies (A) stock among 22 Wall Street analysts is predominantly 'Buy'. The overall Wall Street score is 73 out of 100, reflecting strong analyst conviction in the company's prospects."
  },
  {
   "question": "Are there any significant insider transactions for Agilent Technologies (A)?",
   "answer": "Insider activity for Agilent Technologies (A) shows a 'Moderate Sell Signal', with $4.2 million in total sales and no reported purchases in recent filings. While this indicates a net selling trend among insiders, it does not represent a strong bearish signal."
  },
  {
   "question": "What is the upside potential for Agilent Technologies (A) based on analyst targets?",
   "answer": "Based on the median analyst price target of $177.50, Agilent Technologies (A) has an upside potential of 22.6% from its current trading price of $144.75."
  },
  {
   "question": "What is Agilent Technologies' (A) stock price prediction for 2030?",
   "answer": "A Monte Carlo simulation projects Agilent Technologies' (A) stock price to reach a base case of $210.71 by 2030, with a downside projection of $102.22 and an upside projection of $434.38. These are statistical outcomes, not guarantees."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "ELV",
    "name": "Elevance Health, Inc. NYSE",
    "price": "$416.94",
    "change": "+0.0960%",
    "url": "https://clearank.com/stock/elv-stock-analysis/"
   },
   {
    "ticker": "ILMN",
    "name": "Illumina Inc. NASDAQ",
    "price": "$206.28",
    "change": "+2.49%",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "NVO",
    "name": "Novo Nordisk A/S Sponsored NYSE",
    "price": "$44.01",
    "change": "-1.23%",
    "url": "https://clearank.com/stock/novo-nordisk-nvo/"
   },
   {
    "ticker": "QDEL",
    "name": "QuidelOrtho Corporation NASDAQ",
    "price": "$12.15",
    "change": "-3.88%",
    "url": "https://clearank.com/stock/quidelortho-qdel/"
   },
   {
    "ticker": "CAPR",
    "name": "Capricor Therapeutics, Inc. NASDAQ",
    "price": "$8.30",
    "change": "-3.94%",
    "url": "https://clearank.com/stock/capr-stock-analysis/"
   },
   {
    "ticker": "RXRX",
    "name": "Recursion Pharmaceuticals, Inc. NASDAQ",
    "price": "$3.20",
    "change": "+1.11%",
    "url": "https://clearank.com/stock/rxrx-stock-analysis/"
   },
   {
    "ticker": "DHR",
    "name": "Danaher Corp. NYSE",
    "price": "$200.53",
    "change": "-2.11%",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   },
   {
    "ticker": "ISRG",
    "name": "Intuitive Surgical Inc. NASDAQ",
    "price": "$358.08",
    "change": "+1.37%",
    "url": "https://clearank.com/stock/intuitive-surgical-isrg/"
   }
  ],
  "comparisons": [
   {
    "ticker": "VUG vs VGT Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vug-vs-vgt/"
   },
   {
    "ticker": "NFLX vs DIS Comparison",
    "name": "",
    "url": "https://clearank.com/compare/nflx-vs-dis/"
   },
   {
    "ticker": "Workday (WDAY) vs Atlassian (TEAM) Comparison",
    "name": "",
    "url": "https://clearank.com/compare/workday-vs-atlassian/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "GWRE",
    "text": "Guidewire Software Inc.",
    "url": "https://clearank.com/stock/gwre-stock-analysis/"
   },
   {
    "ticker": "ROST",
    "text": "Ross Stores Inc.",
    "url": "https://clearank.com/stock/rost-stock-analysis/"
   },
   {
    "ticker": "LUGDF",
    "text": "Lundin Gold Inc",
    "url": "https://clearank.com/stock/lugdf-stock-analysis/"
   },
   {
    "ticker": "KEYS",
    "text": "Keysight Technologies, Inc.",
    "url": "https://clearank.com/stock/keys-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "SOXL",
    "text": "↓ 8.03%",
    "url": "https://clearank.com/etf/direxion-semiconductor-bull-soxl/"
   },
   {
    "ticker": "WOLF",
    "text": "↓ 7.73%",
    "url": "https://clearank.com/stock/wolfspeed-wolf/"
   },
   {
    "ticker": "NEAR/USD",
    "text": "↑ 18.46%",
    "url": "https://clearank.com/crypto/near-protocol-near-usd/"
   },
   {
    "ticker": "THETA/USD",
    "text": "↑ 15.25%",
    "url": "https://clearank.com/crypto/theta-network-theta-usd/"
   },
   {
    "ticker": "HPE",
    "text": "↑ 10.41%",
    "url": "https://clearank.com/stock/hewlett-packard-enterprise-hpe/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "DHR",
    "text": "Danaher",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   },
   {
    "ticker": "IDXX",
    "text": "IDEXX",
    "url": "https://clearank.com/stock/idxx-stock-analysis/"
   },
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "IQV",
    "text": "IQVIA Holdings Inc.",
    "url": "https://clearank.com/stock/iqvia-iqv/"
   },
   {
    "ticker": "NTRA",
    "text": "Natera, Inc.",
    "url": "https://clearank.com/stock/natera-ntra/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/08/A-agilent-technologies-analysis-2026-08.png",
     "url": "https://clearank.com/wp-content/uploads/2026/08/A-agilent-technologies-analysis-2026-08.png",
     "width": "1280",
     "height": "720",
     "caption": "Agilent Technologies, Inc. (A) stock price analysis chart for August 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/agilent-technologies-a/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/agilent-technologies-a/",
        "name": "Agilent Technologies Inc. (A) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/agilent-technologies-a/#webpage",
     "url": "https://clearank.com/stock/agilent-technologies-a/",
     "name": "Agilent (A) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-08-26T09:27:16+00:00",
     "dateModified": "2026-09-09T23:33:15+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/08/A-agilent-technologies-analysis-2026-08.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/agilent-technologies-a/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Agilent (A) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-08-26T09:27:16+00:00",
     "dateModified": "2026-09-09T23:33:15+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Is Agilent Technologies (A) a Buy or Sell today? AI price target, moving average signals and valuation risk in one view. Updated daily.",
     "name": "Agilent (A) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/agilent-technologies-a/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/agilent-technologies-a/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/08/A-agilent-technologies-analysis-2026-08.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/agilent-technologies-a/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Agilent Technologies, Inc. (A)",
   "tickerSymbol": "A",
   "url": "https://clearank.com/stock/agilent-technologies-a/",
   "description": "AI-powered financial analysis for Agilent Technologies, Inc. (A) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NYSE",
   "offers": {
    "@type": "Offer",
    "price": 143.12,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/agilent-technologies-a/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is Agilent Technologies (A) stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Agilent Technologies (A) is currently rated a 'Buy' by Wall Street analysts, with a median price target of $177.50, suggesting a 22.6% upside from its current price of $144.75. The company has a history of beating earnings estimates and shows consistent revenue growth."
     }
    },
    {
     "@type": "Question",
     "name": "What is Agilent Technologies' (A) long-term outlook?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The long-term outlook for Agilent Technologies (A) appears positive, with a projected 2030 base case price of $210.71 from Monte Carlo simulations. The company is expected to continue its revenue growth trajectory, supported by its strong position in the healthcare diagnostics and research sector."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key growth drivers for Agilent Technologies (A)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key growth drivers for Agilent Technologies (A) include its consistent innovation in diagnostics and research, strong execution leading to regular earnings beats, and steady revenue growth projected at 8.1% for the current year. The company's ability to maintain analyst confidence also supports its growth prospects."
     }
    },
    {
     "@type": "Question",
     "name": "How has Agilent Technologies (A) performed in recent earnings reports?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Agilent Technologies (A) has consistently surpassed analyst EPS expectations in recent quarters. The latest report in August 2026 showed an 8.72% positive surprise, and the stock saw a 1.68% increase following the announcement, indicating positive market reception to its earnings performance."
     }
    },
    {
     "@type": "Question",
     "name": "What is the consensus rating for Agilent Technologies (A) stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The consensus rating for Agilent Technologies (A) stock among 22 Wall Street analysts is predominantly 'Buy'. The overall Wall Street score is 73 out of 100, reflecting strong analyst conviction in the company's prospects."
     }
    },
    {
     "@type": "Question",
     "name": "Are there any significant insider transactions for Agilent Technologies (A)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insider activity for Agilent Technologies (A) shows a 'Moderate Sell Signal', with $4.2 million in total sales and no reported purchases across 46 transactions. While this indicates a net selling trend among insiders, it does not represent a strong bearish signal."
     }
    },
    {
     "@type": "Question",
     "name": "What is the upside potential for Agilent Technologies (A) based on analyst targets?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on the median analyst price target of $177.50, Agilent Technologies (A) has an upside potential of 22.6% from its current trading price of $144.75."
     }
    },
    {
     "@type": "Question",
     "name": "What is Agilent Technologies' (A) stock price prediction for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "A Monte Carlo simulation projects Agilent Technologies' (A) stock price to reach a base case of $210.71 by 2030, with a downside projection of $102.22 and an upside projection of $434.38. These are statistical outcomes, not guarantees."
     }
    }
   ]
  }
 ]
}